NCT00429962View on ClinicalTrials.gov

Study Comparing Ranibizumab Monotherapy With Combined Verteporfin Therapy in Subfoveal CNV

PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions
Choroidal NeovascularizationAge-Related Macular Degeneration
Interventions
DRUG

intravitreal ranibizumab

intraocular injection

DRUG

intravitreal ranibizumab & photodynamic therapy

intraocular injection photodynamic treatment (LASER) after intravenous injection

Trial Locations (1)

4031

University Eye Clinic, Basel

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER

NCT00429962 - Study Comparing Ranibizumab Monotherapy With Combined Verteporfin Therapy in Subfoveal CNV | Biotech Hunter | Biotech Hunter